cutaneous rosai–dorfman disease preceding inguinal lymphadenopathy
TRANSCRIPT
International Journal of Dermatology 2002, 41, 404–406 © 2002 The International Society of Dermatology
404
A 33-year-old man presented with asymptomatic, gradually progressing, reddish nodules on the
thigh of 1 year’s duration. Six months later, nodules were noticed on the buttock of the same side.
At the same time, the inguinal and femoral lymph nodes increased in size and could be seen
as an elevated mass in the groin which, although painless, made the patient limp when walking.
On examination, a cluster of pink nodules on an erythematous, oval, indurated area,
measuring 10 cm × 5 cm, was seen on the lower medial aspect of the right thigh (Fig. 1). A
small, almost circular, cluster of papules was present on the lower part of the right buttock. Some
of these lesions, according to the patient, were reducing in size. The right inguinal and femoral
lymph nodes were markedly enlarged and firm. The overlying skin was normal. Clinical
differential diagnoses of dermatofibrosarcoma and localized, cutaneous T-cell lymphoma were
considered in this patient. Systemic examination revealed no abnormality.
Routine investigations showed a normal hemogram with an erythrocyte sedimentation rate
(ESR) of 25 mm/h. Urinanalysis, serum proteins, liver and renal function, chest X-ray, and
paranasal sinuses were within normal limits. Peripheral blood smear examination did not show
any abnormal cells. Immunoglobulin (Ig) levels showed: IgG, 12.9 g/L (reference range,
5.6–14.5 g/L); IgA, 4.6 g/L (reference range, 0.45–3.64 g/L); IgM, 0.7 g/L (reference range,
0.03–2.09 g/L).
An incisional biopsy was taken from the skin lesion and fine needle aspiration (FNA) of the
inguinal nodes was performed. FNA smears were moderately cellular. The cell population,
predominantly polymorphic, comprised mature lymphocytes, plasma cells, neutrophils, and
histiocytes. The histiocytes were large, having abundant cytoplasm, and the most prominent
feature was the presence of lymphocytes and plasma cells engulfed within the histiocyte
cytoplasm (emperipolesis) (Fig. 2). Skin biopsy from the lesion showed an essentially
unremarkable epidermis. The entire dermis was densely infiltrated by a polymorphic
inflammatory cell population. The predominant cell population was made up of large
histiocytes having abundant pale cytoplasm. Plenty of lymphocytes arranged in a nodular
pattern were also seen between the histiocytes. Plasma cells, neutrophils, and a few
eosinophils were also interspersed. The striking feature was, however, engulfed neutrophils and
lymphocytes within the histiocyte cytoplasm (emperipolesis) (Fig. 3). Immunohistochemical
stains revealed S-100 positivity in the histiocytes (Fig. 4). The cytologic, histologic, and
immunohistochemical findings were correlated and a diagnosis of Rosai–Dorfman disease
was made.
Blackwell Science, LtdOxford, UKIJDInternational Journal of Dermatology0011-9059Blackwell Science, 2002?CameoCutaneous Rosai–Dorfman diseaseUniyal et al.CameoCutaneous Rosai–Dorfman disease preceding inguinal lymphadenopathy
Shailesh K. Uniyal, MD, K. R. Beena, MD, V. Ramesh, MD, and Ashok Mukherjee, MD
From the Department of Dermatology and Institute of Pathology (ICMR), Safdarjang Hospital Campus, New Delhi, India
Correspondence Shailesh K. Uniyal, MD Department of DermatologySafdarjang HospitalNew Delhi – 110 029IndiaE-mail: [email protected]
Discussion
Rosai–Dorfman disease is a histiocytic disorder with anunknown etiopathogenesis. The disease affects all age groups,but is most common during the first and second decades oflife. The disorder does not show predilection for any ethnic groupor gender. It is a benign, self-limiting disease, often involvingthe lymph nodes, especially the cervical nodes. Extranodalinvolvement occurs in 30–40% of cases.1 Any organ in the
body can be involved, especially the skin, upper respiratorytract, salivary glands, bone, central nervous system, andsoft tissues.2 Extranodal localization may be the predominantor exclusive disease manifestation, as exemplified in this case.
Rosai–Dorfman disease, or sinus histiocytosis with massivelymphadenopathy, was first described by Rosai and Dorfmanin 1969.3 A registry of this entity contains records and patho-logic samples from over 600 cases.4 Pure cutaneous lesionswere reported for the first time in 1978.5
© 2002
The International Society of Dermatology International Journal of Dermatology
2002,
41
, 404–406
405
Uniyal
et al. Cutaneous Rosai–Dorfman disease
Cameo
The etiology of the disease is unknown. It is a disorder ofthe mononuclear phagocyte and immunoregulator effectorsystem.
2
An abnormal response of histiocytes to an infectivestimulus is hypothesized. Human herpes virus 6 (HHV 6) hasbeen detected in involved tissues.
6
Elevated Epstein–Barr virusand herpes simplex virus antibody titers have been reported.
7,8
Clonal analysis performed in cases of Rosai–Dorfman diseaseshow that the cell infiltrate is polyclonal in nature, thussupporting a reactive rather than a neoplastic process.
9
Cutaneous lesions present as solitary or multiple papules,nodules, or plaques. Lesions may occasionally appear pso-riasiform or acneiform. The cervical lymph nodes are usuallythe most common node involved, followed by the axillary,inguinal or para-aortic, and mediastinal nodes. The patientmay also show features of anemia, an elevated erythrocyte
sedimentation rate (ESR), leukocytosis, and hypergamma-globulinemia. The disease is often associated with immunedisorders, preceding or occurring at the same time. Commonabnormalities are the presence of autoantibodies (againstred cell antigens), joint diseases (polyarthralgia to severearthritis), severe infections (pneumonia), glomerulonephritis,asthma, and juvenile-onset diabetes mellitus.
10
The diagnosis of Rosai–Dorfman disease in a nodal/extra-nodal site is indicated by the classic histologic/cytologicpattern: a polymorphous infiltrate together with histiocytesexhibiting features of emperipolesis. The latter feature,although not totally specific, provides an important clue tothe diagnosis.
Immunohistochemical stains provide a good aid to diag-nosis. The histiocytes show strong and consistent positivity to
Figure 1 Cluster of reddish nodules over the thigh
Figure 2 Photomicrograph of fine needle aspiration smears showing large histiocytes with engulfed lymphocytes and plasma cells (emperipolesis) (Giemsa, × 400)
Figure 3 Photomicrograph from the cutaneous nodule showing a dermal infiltrate of histiocytes, lymphocytes, neutrophils, and plasma cells. The large histiocytes reveal emperipolesis (hematoxylin and eosin, × 400)
Figure 4 Photomicrograph from the skin lesion showing a positive staining reaction with S-100 antibody within the histiocyte cytoplasm (avidin–biotin peroxidase, × 400)
IJD_1534.fm Page 405 Monday, July 1, 2002 3:45 PM
International Journal of Dermatology
2002,
41
, 404–406 © 2002
The International Society of Dermatology
406 Cameo
Cutaneous Rosai–Dorfman disease
Uniyal
et al.
S-100 protein. Positive staining reactions are also observedwith CD14, CD68, CD30, CD25,
α
1-antitrypsin, and cathe-psin D and E.
Clinically and histologically, it may be important to differ-entiate Rosai–Dorfman disease from benign and malignantfibrous histiocytoma, large cell lymphoma, Hodgkin’slymphoma, Langerhans’ cell histiocytosis, melanoma, andmetastatic carcinoma. Emperipolesis is observed in many ofthese conditions.
Pure cutaneous lesions of Rosai–Dorfman disease are rare.It is not clear whether these cases actually remain limited tothe skin or whether they are associated with an undetectednodal or systemic lesion which may manifest later. This wasobserved in the present case.
The disease usually undergoes spontaneous regression, asobserved in our patient. There may occasionally be a chroniccourse or disseminated nodal or systemic involvement,however. Treatment is usually not required. Superficial X-rayor cryotherapy are viable therapeutic options. A combinationof vinca alkaloids and corticosteroids may be of value. Ourpatient was informed about the possibility of spontaneousremission, but desired active intervention. Cryotherapyfollowed by intralesional triamcinolone was started and wasgiven at intervals of 3 weeks. Skin lesions showed markedregression.
Poor prognostic signs include widespread dissemination,organ involvement, immunologic abnormalities, anemia,lymphocytopenia, and elevated ESR. A diagnostic work-upfor immunologic abnormalities, computed tomography,magnetic resonance imaging, and radionuclide bone scanningmay be helpful for follow-up and evaluation.
References
1 Skiljo M, Garcia-Lora E, Tercerdor J,
et al.
Purely cutaneous Rosai–Dorfman disease.
Dermatology
1995;
191
: 49–51.2 Carbone A, Passannante A, Gloghini A,
et al.
Review of sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman disease) of the head and neck.
Ann Otol Rhinol Laryngol
1999;
108
: 10,095–11,104.3 Rosai J, Dorfman RF. Sinus histiocytosis with massive
lymphadenopathy: a new recognised benign clinicopathological entity.
Arch Pathol
1969;
87
: 63–70.4 Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with
massive lymphadenopathy (Rosai Dorfman disease): review of the entity.
Semin Diagn Pathol
1990;
7
: 19–73.5 Thawerani H, Sanchez RL, Rosai J, Dorfman RF. The
cutaneous manifestations of sinus histiocytosis with massive lymphadenopathy.
Arch Dermatol
1978;
114
: 191–197.6 Levine PH, Jahan N, Murari P,
et al.
Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy.
J Infect Dis
1992;
166
: 291–295.7 Lazar AP, Esterly NB, Gonzales-Crussi F. Sinus histiocytosis
clinically limited to the skin.
Pediatr Dermatol
1987;
4
: 247–253.
8 Perez A, Rodriguez M, Febrer I, Aliaga A. Sinus histiocytosis confined to the skin: case report and review of literature.
Am J Dermatopathol
1995;
17
: 384–388.9 Paulli M, Bergamaschi G, Tonon L. Evidence for a
polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman disease).
Br J Haematol
1995;
91
: 415–418.10 Maennle DL, Grierson HL, Gnarra DG, Weisenburger DD.
Sinus histiocytosis with massive lymphadenopathy: a spectrum of disease associated with immune dysfunction.
Pediatr Pathol
1994;
25
: 88–90.
IJD_1534.fm Page 406 Monday, July 1, 2002 3:45 PM